Skip to content
healthcare.dev

Mesalamine

NDC 84612-175, Mesalamine, tablet, delayed release, from Nuvaila Limited.

Product NDC
84612-175
Status
Listed
Labeler
Nuvaila Limited
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84612-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE1.2 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
84612-175-1384612017513120 TABLET, DELAYED RELEASE in 1 BOTTLE (84612-175-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/875d573f-99a1-426a-8321-4d511690d503

Use it

Look up 84612-175 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84612-175 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84612-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.